Log in

Melinta Therapeutics SEC Filings & 10K Form (NASDAQ:MLNT)

$4.28
-0.10 (-2.28 %)
(As of 10/21/2019 03:10 AM ET)
Today's Range
$3.85
Now: $4.28
$4.41
50-Day Range
$2.21
MA: $3.25
$4.58
52-Week Range
$1.62
Now: $4.28
$19.85
Volume356,145 shs
Average Volume445,000 shs
Market Capitalization$58.85 million
P/E RatioN/A
Dividend YieldN/A
Beta4.54

SEC Filings

Melinta Therapeutics (NASDAQ:MLNT) SEC Filings

DateFilerForm TypeView
09/13/2019
1:59 PM
Melinta Therapeutics (Issuer)
Sanfilippo Jennifer A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2019
3:25 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
8:35 PM
Melinta Therapeutics (Subject)
Vatera Healthcare Partners LLC (Filed by)
Form SC 13D/A
08/09/2019
6:40 AM
Melinta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
6:37 AM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
3:50 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2019
1:58 PM
FMR LLC (Filed by)
Melinta Therapeutics (Subject)
Form SC 13G/A
07/02/2019
8:09 PM
JOHNSON JOHN (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:18 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2019
3:06 PM
JOHNSON JOHN (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
12:37 PM
Ferro Kevin (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
12:37 PM
DOWNEY BRUCE (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
12:37 PM
GILL DAVID N (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
12:36 PM
Melinta Therapeutics (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
12:36 PM
Koestler Thomas P (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
12:36 PM
Galeota James JR (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:31 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
7:23 PM
Cammarata Sue (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
7:21 PM
Melinta Therapeutics (Issuer)
Milligan Peter J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
4:30 PM
Melinta Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/10/2019
3:20 PM
Melinta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
3:16 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
8:37 PM
Melinta Therapeutics (Filer)
Form DEF 14A
03/13/2019
9:02 PM
Melinta Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2019
3:04 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2019
8:47 PM
JOHNSON JOHN (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
4:18 PM
Ferro Kevin (Reporting)
Melinta Therapeutics (Issuer)
Vatera Capital Management LLC (Reporting)
Vatera Healthcare Partners LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
4:16 PM
Melinta Therapeutics (Subject)
Vatera Healthcare Partners LLC (Filed by)
Form SC 13D/A
02/25/2019
7:15 AM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2019
4:22 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
3:18 PM
Melinta Therapeutics (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
02/13/2019
5:14 AM
Melinta Therapeutics (Filer)
Form DEFA14A
02/04/2019
8:34 AM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2019
8:32 AM
Melinta Therapeutics (Filer)
Form DEFA14A
01/28/2019
8:34 PM
Melinta Therapeutics (Filer)
Form DEFR14A
01/16/2019
2:21 PM
Flynn James E (Filed by)
Melinta Therapeutics (Subject)
Form SC 13G/A
01/15/2019
4:18 PM
Melinta Therapeutics (Filer)
Form PRER14A
01/11/2019
4:07 PM
Melinta Therapeutics (Issuer)
Vatera Capital Management LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2019
4:20 PM
Melinta Therapeutics (Subject)
Vatera Healthcare Partners LLC (Filed by)
Form SC 13D/A
01/02/2019
8:57 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2019
8:55 PM
Melinta Therapeutics (Filer)
Form DEFA14A
12/20/2018
4:22 PM
Melinta Therapeutics (Subject)
VATERA HOLDINGS LLC (Filed by)
Form SC 13D/A
12/19/2018
4:06 PM
Melinta Therapeutics (Filer)
Form DEFA14A
12/19/2018
4:03 PM
Melinta Therapeutics (Filer)
Form DEFA14A
12/19/2018
3:01 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
3:00 PM
Melinta Therapeutics (Filer)
Form DEFA14A
12/10/2018
2:30 PM
Melinta Therapeutics (Filer)
Form DEFA14A
12/03/2018
4:36 PM
DOWNEY BRUCE (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
4:13 PM
Melinta Therapeutics (Filer)
Form DEF 14A
11/21/2018
3:40 PM
Melinta Therapeutics (Subject)
VATERA HOLDINGS LLC (Filed by)
Form SC 13D/A
11/19/2018
4:20 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2018
4:14 PM
Melinta Therapeutics (Filer)
Form PRE 14A
11/16/2018
3:54 PM
Melinta Therapeutics (Filer)
Form S-8 POS
11/16/2018
3:51 PM
Melinta Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/09/2018
5:11 PM
DOWNEY BRUCE (Reporting)
Melinta Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/08/2018
3:31 PM
Melinta Therapeutics (Subject)
VATERA HOLDINGS LLC (Filed by)
Form SC 13D/A
11/07/2018
7:27 AM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
7:14 AM
Melinta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2018
4:21 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2018
4:10 PM
Melinta Therapeutics (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G
10/29/2018
4:30 PM
JOHNSON JOHN (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2018
3:59 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2018
4:18 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2018
3:55 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2018
4:03 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2018
5:05 PM
Melinta Therapeutics (Issuer)
Milligan Peter J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
5:04 PM
Melinta Therapeutics (Issuer)
Milligan Peter J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/19/2018
8:23 AM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2018
9:02 AM
FMR LLC (Filed by)
Melinta Therapeutics (Subject)
Form SC 13G/A
09/04/2018
2:34 PM
Melinta Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/04/2018
2:31 PM
Melinta Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/09/2018
7:18 AM
Melinta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2018
8:15 AM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2018
3:59 PM
Koestler Thomas P (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:58 PM
JOHNSON JOHN (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:55 PM
GONZALO CECILIA (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:54 PM
Melinta Therapeutics (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:54 PM
Ferro Kevin (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:53 PM
GILL DAVID N (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:53 PM
Cammarata Sue (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:53 PM
Kong Garheng (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:53 PM
Galeota James JR (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:51 PM
Duffy Erin (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:48 PM
Estrem Paul (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:48 PM
Melinta Therapeutics (Issuer)
Wechsler Daniel Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:37 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
8:59 AM
FMR LLC (Filed by)
Melinta Therapeutics (Subject)
Form SC 13G
06/08/2018
3:39 PM
Melinta Therapeutics (Filer)
Form 8-K/A
05/31/2018
4:22 PM
Estrem Paul (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
4:14 PM
Melinta Therapeutics (Issuer)
ZACCARDELLI DAVID (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
4:13 PM
Duffy Erin (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
4:13 PM
Melinta Therapeutics (Issuer)
Wechsler Daniel Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
4:13 PM
Ferro Kevin (Reporting)
Melinta Therapeutics (Issuer)
Vatera Healthcare Partners LLC (Reporting)
VATERA HOLDINGS LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
4:12 PM
Cammarata Sue (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
4:08 PM
Melinta Therapeutics (Subject)
VATERA HOLDINGS LLC (Filed by)
Form SC 13D/A
05/30/2018
3:38 PM
GILL DAVID N (Reporting)
Melinta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2018
4:18 PM
Melinta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2018
5:09 AM
Melinta Therapeutics (Filer)
Form 424B5
05/21/2018
3:13 PM
Melinta Therapeutics (Subject)
Form FWP
05/21/2018
3:04 PM
Melinta Therapeutics (Filer)
Form 424B5
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel